In MPTP-induced PD mouse models, TFA administration via gavage increased the expression of SLC7A11 and GPX4, raised the GSH/GSSG ratio, enhanced cellular antioxidant capacity, and inhibited neuronal ferroptosis [118]. This evidence concerns the gene GPX4 and Parkinson disease.